Showing results (181-190 of 332) with videos related to

Sort By:
Pageof 34
Bone Marrow Transplantation|February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMTJaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
European Journal of Haematology|April 4, 2017
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Elsa Lestang, Pierre Peterlin, Yannick Le Bris, et al.
Transplantation|July 17, 2012
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?Pierre Peterlin, Christophe Leux, Thomas Gastinne, et al.
Blood Advances|September 8, 2021
Activation status dictates the function of unlicensed natural killer cells in mice and humansEthan G Aguilar, Cordelia Dunai, Sean J Judge, et al.
Blood Advances|November 9, 2022
Outcomes of subsequent neoplasms after umbilical cord blood transplantation in EuropeHanadi Rafii, Annalisa Ruggeri, Chantal Kenzey, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.
JCI Insight|August 1, 2024
Human gut microbiota-reactive DP8α Tregs prevent acute graft-versus-host disease in a CD73-dependent mannerEmmanuelle Godefroy, Patrice Chevallier, Fabienne Haspot, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Cancer|February 23, 2018
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer CenterStefan O Ciurea, Myriam Labopin, Gerard Socie, et al.
Pageof 34